Home
>
National Drug Code (NDC)
>
Periogard
Periogard - 0126-0271-16 - (Chlorhexidine Gluconate)
Drug Information of Periogard
| Product NDC: | 0126-0271 |
| Proprietary Name: | Periogard |
| Non Proprietary Name: | Chlorhexidine Gluconate |
| Active Ingredient(s): | 1.2 mg/mL & nbsp; Chlorhexidine Gluconate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Periogard
| Product NDC: | 0126-0271 |
| Labeler Name: | Colgate-Palmolive Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA073695 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100302 |
Package Information of Periogard
| Package NDC: | 0126-0271-16 |
| Package Description: | 473 mL in 1 BOTTLE (0126-0271-16) |
NDC Information of Periogard
| NDC Code | 0126-0271-16 |
| Proprietary Name | Periogard |
| Package Description | 473 mL in 1 BOTTLE (0126-0271-16) |
| Product NDC | 0126-0271 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Chlorhexidine Gluconate |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20100302 |
| Marketing Category Name | ANDA |
| Labeler Name | Colgate-Palmolive Company |
| Substance Name | CHLORHEXIDINE GLUCONATE |
| Strength Number | 1.2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Cell Wall Integrity [PE] |
